Inoperable locally advanced non-small cell lung cancer: Survival rates of Endostar, CCRT Inoperable locally advanced non-small cell lung cancer (NSCLC): An Introduction Accounting for approximately 80% of lung cancers, non-small cell lung cancer (NSCLC) is the most common subtype. Most NSCLC patients are diagnosed at an advanced stage with a mere 15-20%
Author: Nivil Gopi
Physician Spending And Its Association With Patient Outcomes
Physician Spending And Its Association With Patient Outcomes Global spending on health is soaring at a rapid rate. The total health expenditure (THE) worldwide increased from US$ 7.6 trillion in 2016 to US$ 7.8 trillion in 2017. The World Health Organization 2020 report stated that it reached US$ 8.3 trillion or
Physician Burnout: Causes and Prevention
Physician Burnout: Causes and Prevention The data is indisputable: Physicians across the globe are emotionally drained and overworked due to increasing demands on the profession. Numerous global studies indicate that one in every three physicians experiences burnout at any given time. Originally used by Herbert Freudenberger in 1974 and subsequently described by
LEAP-MS: Adaptions for Advanced Stages
LEAP-MS: Adaptions for Advanced Stages Lifestyle, Exercise and Activity Package for People Living with Progressive Multiple Sclerosis (LEAP-MS): adaptations for remote delivery & improved efficiency Multiple sclerosis (MS) is the most common neurologic disorder of young and middle-aged adults. MS expresses itself in four clinical forms: relapsing-remitting MS (RRMS), secondary progressive MS
Extrapontine Myelinolysis and Pituitary Tumor Apoplexy in Pregnancy
Extrapontine Myelinolysis and Pituitary Tumor Apoplexy in Pregnancy Background Pituitary tumor apoplexy (PTA) is an uncommon but potentially fatal clinical emergency resulting from abrupt ischemic infarction or hemorrhage of the pituitary tumor. A variety of precipitating factors has been linked to PTA, including pregnancy. However, gestational pituitary apoplexy is limited to isolated
SGLT inhibitors on weight and lipid metabolism in diabetes
SGLT inhibitors on weight and lipid metabolism in diabetes Diabetes mellitus (DM), is a diagnostic term for a group of metabolic disorders characterized by abnormal glucose homeostasis resulting in elevated blood sugar. Almost 90% of people with diabetes have type 2 diabetes (T2DM). Currently, more than 463 million people are living
Grave’s Disease and Risk of Systemic Lupus Erythematosus
Grave's disease and risk of incident SLE: A nationwide population-based cohort study BACKGROUND Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that causes damage to multiple tissues and organs, including the thyroid gland. Several authors have linked Grave’s disease, an autoimmune disease characterized by an overactive thyroid gland, to incident
Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy
Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy Background In 2021, there will be an estimated 76,080 new cases of kidney cancer in the US (48,780 in men and 27,300 in women) and about 13,780 patients (4,990 women, 8,790 men) will die from this disease. The most common form of kidney
Thermography in clinical ophthalmic oncology
THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest
Technology-assisted methadone take-home dosing for patients with opioid use disorder
Technology-assisted methadone take-home dosing for patients with opioid use disorder Methadone maintenance treatment (MMT) is the most prevalent and effective treatment for opioid dependence. Sometimes, ‘take home’ privileges are offered to patients with Opioid Use Disorder (OUD); however, it is limited to the patients with regular clinical and counseling attendance, and
